(PDF) Statins and Risk of Decompensation in Hepatitis B

Statins and Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: Methodological Issues

Hepatology - United States

doi 10.1002/hep.29687

Full Text

Abstract

Available in full text

Categories

Date

January 30, 2018

Authors

Publisher

Wiley

Related search

Statins Decrease the Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: A Population-Based Study

English

Reply: Statins Decrease the Risk of Decompensation in Hepatitis B Virus- And Hepatitis C Virus-Related Cirrhosis: A Population-Based Study

English

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection

International Journal of Medical Sciences

English

Detection of Hepatitis Virus B and C in Archival Autopsy Specimens of Liver Cirrhosis

Biomedical Journal of Scientific & Technical Research

English

Hepatocellular Carcinoma Complicating Hepatitis E Virus-Related Cirrhosis

English

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

English

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)

Infectious Diseases

English

Seroprevalance of Hepatitis B Virus, Human Immunodeficiency Virus and Hepatitis C Virus Among Blood Donors: A Retrospective Study

Tropical Journal of Pathology and Microbiology

English

Statin and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis

BMC Gastroenterology

Gastroenterology

English